Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
Community Search
Share |

Note: SAPAA webinars are hosting using GoToWebinar.  To successfully participate, you must have speakers or be able to dial a long-distance conference number while sitting at your computer or mobile device.  To register for a webinar, click on the link at the end of the training description.  If you experience any difficulty registering for a webinar, please contact SAPAA at 1-800-672-7229 or



There are not any webinars currently scheduled.  Please review our recorded webinars below.


Don't Panic!  Employers Should Be Able to Continue Most Post-Accident Drug Tests Under OSHA’s New “Reasonable Reporting Procedure” Rule  (Original Webinar July 27, 2016)


The Occupational Safety and Health Administration (OSHA) is enforcing the nation’s workplace safety laws through a variety of new and creative approaches, accelerated rule making, and workplace inspection initiatives.  Along with substantially increasing maximum penalties by 78% effective August 1, 2016, and mandating electronic reporting by employers, it has interjected the Agency in the whole field of post-accident workplace drug testing.  Employers who choose not to heed OSHA’s announcements contained in its Final Rule may face considerable economic liability and employee retaliation claims.  The regulations are effective November 1, 2016.

This presentation will educate employers that they need not panic about post-accident drug testing under the regulations to become effective on November 1, 2016, but gives them 7 common sense counsel risk reduction steps to keep their program out of OSHA’s cross-hairs.   

Dennis Kerns of GDK Global Consulting, LLC and Tommy Eden of Constangy, Brooks, Smith & Prophete, LLP, Workplace Drug & Alcohol Testing Practice Group will be the presenters for this webinar. NOTE:  This presentation is for educational purposes only and is not intended as a substitute for the legal advice of an attorney knowledgeable in the field of work place drug and alcohol testing.  

The presenter(s) make(s) no assurances regarding the accuracy or completeness of the following information: Legislative, regulatory or case law.



Webinar Disclaimer: As with any SAPAA presentation, the opinions of the presenter(s) and/or sponsor(s) do not necessarily represent the position or opinion of SAPAA, its Board of Directors, or its members.  Additionally, any reference to a specific commercial product, process, or service by trade name, trademark, manufacturer, corporation, or otherwise does not constitute or imply endorsement, recommendation, or favoring by SAPAA.

Sign In

Forgot your password?

Haven't registered yet?